Insider Trading & SAST disclosures for Gujarat Themis Biosyn Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
Pharmaceutical Business Group [India] Ltd in Gujarat Themis Biosyn Ltd. where Disposal of 3,000,000
Equity Shares done at an average price of Rs. 215.1
was reported to the exchange on Dec. 29, 2023.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Pharmaceutical Business Group India Ltd in Gujarat Themis Biosyn Ltd. where Disposal of 3,000,000
shares done
was reported to the exchange on Dec. 28, 2023.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Pharmaceutical Business Group [India] Ltd
|
Promoter Group |
Disposal |
29 Dec 2023 |
3,000,000 |
34,160,000
(47.02%)
|
4.13%
|
215.1 |
645,385,126
|
27 Dec 2023
27 Dec 2023 |
Insider Trading |
Equity Shares |
Block Deal |
|
Pharmaceutical Business Group India Ltd
|
Promoter |
Disposal |
09 Jan 2024 |
3,000,000 |
34,160,000
(47.02%)
|
4.13%
|
|
-
|
27 Dec 2023
27 Dec 2023 |
SAST (29(2)) |
- |
Block Trade |
|
Mrs.Avantika Vijay Agarwal
|
Directors Immediate Relative |
Acquisition |
28 Sep 2023 |
5,400 |
15,008
(0.10%)
|
0.04%
|
913.9 |
4,934,853
|
26 Sep 2023
26 Sep 2023 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Ms. Avantika Vijay Agarwal
|
Directors Immediate Relative |
Disposal |
15 Dec 2021 |
656 |
13,312
(0.09%)
|
0.00%
|
501.5 |
328,976
|
14 Dec 2021
14 Dec 2021 |
Insider Trading |
Equity Shares |
Market Sale |
|
Ms. Avantika Vijay Agarwal
|
Directors Immediate Relative |
Disposal |
15 Dec 2021 |
9,032 |
13,968
(0.10%)
|
0.06%
|
504.0 |
4,551,876
|
13 Dec 2021
13 Dec 2021 |
Insider Trading |
Equity Shares |
Market Sale |
|
Pharmaceutical Business Group (India) Limited
|
Promoter Group |
Acquisition |
20 Sep 2021 |
3,850,000 |
7,432,000
(51.15%)
|
26.50%
|
150 |
577,500,000
|
17 Sep 2021
17 Sep 2021 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Yuhan Corporation
|
Promoter Group |
Disposal |
20 Sep 2021 |
3,850,000 |
0
(0%)
|
26.50%
|
150 |
577,500,000
|
17 Sep 2021
17 Sep 2021 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Pharmaceutical Business Group (India) Ltd & PACs
|
Promoter |
Acquisition |
20 Sep 2021 |
3,850,000 |
7,432,000
(51.15%)
|
26.50%
|
|
-
|
17 Sep 2021
17 Sep 2021 |
SAST (29(2)) |
- |
Off Market / Inter se transfer |
|
Pharmaceutical Business Group (India) Ltd
|
Other |
Acquisition |
20 Sep 2021 |
3,850,000 |
-
|
26.50%
|
|
-
|
17 Sep 2021
17 Sep 2021 |
SAST (10(6)) |
- |
- |
|
Pharmaceutical Business Group India Ltd
|
Promoter |
Disposal |
18 Sep 2021 |
3,850,000 |
-
|
26.50%
|
|
-
|
17 Sep 2021
17 Sep 2021 |
SAST (29(2)) |
- |
Off Market / Inter se transfer |
|
Pharmaceutical Business Group India Ltd
|
Promoter |
Acquisition |
24 Jul 2021 |
3,850,000 |
-
|
26.50%
|
|
-
|
30 Jul 2021
30 Jul 2021 |
SAST (10(1)(a)) |
- |
None |
|
Mr.Rajneesh Anand
|
Designated Person |
Acquisition |
17 Jun 2021 |
5,250 |
25,990
(0.17%)
|
0.04%
|
295.2 |
1,549,842
|
16 Jun 2021
16 Jun 2021 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Mr.Rajneesh Anand
|
Designated Person |
Acquisition |
17 Jun 2021 |
1,750 |
20,740
(0.14%)
|
0.01%
|
286.5 |
501,401
|
15 Jun 2021
15 Jun 2021 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Ms. Indu Vijay Agarwal
|
Directors Immediate Relative |
Disposal |
12 Mar 2021 |
5,000 |
15,750
(0.11%)
|
0.03%
|
214.7 |
1,073,673
|
10 Mar 2021
10 Mar 2021 |
Insider Trading |
Equity Shares |
Market Sale |
|
Ms. Indu Vijay Agarwal
|
Directors Immediate Relative |
Acquisition |
18 Jun 2020 |
5,000 |
20,750
(0.14%)
|
0.03%
|
174.6 |
873,038
|
17 Jun 2020
17 Jun 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Ms. Indu Vijay Agarwal
|
Directors Immediate Relative |
Acquisition |
18 Jun 2020 |
10,774 |
15,750
(0.11%)
|
0.07%
|
173.0 |
1,863,372
|
16 Jun 2020
16 Jun 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Ms. Indu Vijay Agarwal
|
Directors Immediate Relative |
Acquisition |
18 Jun 2020 |
4,976 |
4,976
(0.03%)
|
0.03%
|
174.2 |
866,987
|
15 Jun 2020
15 Jun 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Ms. Avantika Vijay Agarwal
|
Directors Immediate Relative |
Acquisition |
16 Mar 2020 |
8,000 |
23,000
(0.16%)
|
0.06%
|
101.2 |
809,998
|
13 Mar 2020
13 Mar 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Ms. Avantika Vijay Agarwal
|
Directors Immediate Relative |
Acquisition |
13 Mar 2020 |
15,000 |
15,000
(0.10%)
|
0.10%
|
106.5 |
1,597,500
|
11 Mar 2020
11 Mar 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Pharmaceutical Business Group (India) Ltd
|
Promoter |
Disposal |
11 Aug 2014 |
1,423,000 |
3,582,000
(24.65%)
|
9.79%
|
|
-
|
07 Aug 2014
07 Aug 2014 |
SAST (29(2)) |
- |
Offer For Sale |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.